# Heart Rhythm Care Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/heart-rhythm-care-group

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.heartrhythm.cn/
- Latest round: Series C (Mar 19, 2025)
- Investors on record: 6

## About

Based in China, Heart Rhythm Care Group specializes in advanced cardiovascular healthcare solutions, delivering diagnostic and therapeutic services to patients with heart conditions through collaboration with hospitals and healthcare institutions.Founded in 2015, Heart Rhythm Care Group operates out of Beijing, China, focusing on delivering specialized cardiovascular care. The company has successfully completed 3 deals to date. The founder's background information is not available.Heart Rhythm Care Group primarily focuses on providing advanced cardiovascular healthcare solutions, including a range of diagnostic and therapeutic services. Their core offerings encompass specialized medical treatments in cardiology, including electrophysiology training and heart emergency care, tailored to meet the needs of patients with cardiovascular diseases. The company collaborates with a network of prominent hospitals and healthcare institutions across various regions, including North China, Northeast China, and Southeast China, enhancing healthcare access and expertise. Key clients include leading hospitals such as Beijing Anzhen Hospital and Shanghai Renji Hospital, positioning Heart Rhythm Care Group as a trusted partner in delivering high-quality cardiac care. With a commitment to integrating cutting-edge technology, such as Siemens' advanced dual-source CT systems, Heart Rhythm Care Group aims to address critical healthcare challenges faced by patients while ensuring compliance with international healthcare standards.The revenue model of Heart Rhythm Care Group is structured around partnerships with healthcare institutions and direct service offerings to patients. Typically, transactions occur through collaborations with hospitals where Heart Rhythm provides training and expertise in cardiovascular treatments, creating a consistent revenue stream from these partnerships. Additionally, the company may engage in direct-to-consumer services, providing specialized treatments and consultations to patients seeking advanced cardiovascular care. Pricing structures for these services are aligned with industry standards, reflecting the high-quality, advanced medical technologies employed by Heart Rhythm. The company's flagship offerings, particularly in the realm of electrophysiology and cardiac emergency services, are designed to cater to a patient base that values both innovation and reliability in healthcare solutions.In March 2025, Heart Rhythm Care Group raised an undisclosed amount of Series C funding from investors including Lucion Venture Capital, Eastwest Capital, Xin Ding Capital, and Qianhai Infrastructure Investment. The funds will be allocated towards developing new products aimed at enhancing cardiac care and expanding into new geographic markets. The company is currently targeting expansion into additional regions within China, aiming to broaden its reach and impact in cardiovascular healthcare.

## Funding rounds

- Series C, Mar 19, 2025 — Shandong High-tech Investment Corporation, Xin Ding Capital, Shanghai Dongxi Investment Development, Qianhai Infrastructure Investment
- Series B, Jun 17, 2020 — Huaying Investment
- Series A, Dec 12, 2016 — Huarongtianze Investment Company

## Investors

- Huarongtianze Investment Company (https://capitalatlas.ai/funds/huarongtianze-investment-company) — Series A
- Huaying Investment (https://capitalatlas.ai/funds/huaying-investment) — Series B
- Shandong High-tech Investment Corporation (https://capitalatlas.ai/funds/shandong-high-tech-investment-corporation) — Series C
- Xin Ding Capital (https://capitalatlas.ai/funds/xin-ding-capital) — Series C
- Shanghai Dongxi Investment Development (https://capitalatlas.ai/funds/shanghai-dongxi-investment-development) — Series C
- Qianhai Infrastructure Investment — Series C
